The Infectious Diseases Data Observatory (IDDO) is a scientifically independent, multi-disciplinary coalition of the global infectious disease and emerging infections communities. It provides the methods, governance and infrastructure to translate data into evidence that improves outcomes for patients worldwide. Currently, IDDO has eight active areas of research with many more already in development or being scoped for feasibility.
Share data

If you work with clinical, laboratory or epidemiological data and want to share your research or access research data then you are welcome to sign up to the Observatory.

We have platforms for a range of diseases including emerging and neglected infections.

Learn about our approach and governance
Learn about our research themes
What is IDDO?

The Infectious Diseases Data Observatory (IDDO) is a researcher driven network which provides data platforms to capture, share and collaborate on infectious disease related data.

Using years of experience and extensive investment in data tools we provide platforms which are designed for effective data analysis and robust governance.

Find out more about IDDO

COVID-19

Explore our work on COVID-19

Sars cov2 causes covid19
View

Research themes

IDDO enables research-driven responses to major challenges of infectious diseases through development and management of data sharing platforms.

Credit: Wellcome Images
Research themes

Contributing data

Learn more about sharing your data through IDDO

Connected world
Contribute data

Tools and resources

IDDO is committed to providing practical tools and services to support the collection of disease characterisation data and develop quality evidence on optimal treatment and response to emerging infections. 

Credit: MORU
View our resources

News

Participants at MQ informal meeting
News Article
25 Apr 2023
After reviewing progress on improving global medicine quality, participants plan next global conference
marc_se-africa.lighter.jpeg
News Article
14 Apr 2023
WWARN is part of a new consortium tackling malaria drug resistance in South-East Africa
Image of Dr James Watson
i
Dr James Watson
News Article
03 Apr 2023
Dr James Watson becomes IDDO’s new Associate Director
lab_worker_testing_hanoi_credit_simone_d_mccourtie_world_bank.jpg
News Article
24 Mar 2023
Study finds almost two-thirds of patients are systematically excluded from drug trials
View all news items

Latest publications

Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa

BMC Medicine

Published: 13 Apr 2023

Author(s): Godfrey Bwire, Benn Sartorius, Philippe Guerin, Merawi Aragaw Tegegne, Sam I. Okware, Ambrose O. Talisuna

DOI: https://doi.org/10.1186/s12916-023-02847-1

The quality of antiretroviral medicines: an uncertain problem

BMJ Global Health

Published: 15 Mar 2023

Author(s): Ngan Thi Do, Phonepasith Boupha, Paul N Newton, Céline Caillet

DOI: http://dx.doi.org/10.1136/bmjgh-2022-011423

Malaria patient spectrum representation in therapeutic clinical trials of uncomplicated malaria: a scoping review of the literature

Malaria Journal

Published: 10 Feb 2023

Author(s): Lorenzo Arena, Mazvita Zanamwe, Christine M. Halleux, Verena Carrara, Brian J. Angus, Proochista Ariana, Georgina S. Humphreys, Caitlin Richmond, Kasia Stepniewska, Philippe J. Guérin & Piero L. Olliaro

DOI: https://doi.org/10.1186/s12936-023-04441-5

View all publications